Homepharmaceutical stocks

pharmaceutical stocks

CTD Holdings Conducts Initial Review of Safety Data for its Phase I and Phase I/II Trials of Trappsol(R) Cyclo(TM) to Treat Niemann-Pick Disease Type C

CTD Holdings Conducts Initial Review of Safety Data for its Phase I and Phase I/II Trials of Trappsol(R) Cyclo(TM) to Treat Niemann-Pick Disease Type C

March 29, 2018

Teva Pharmaceutical Reports Drop in Q3 Profit, Shares Plunge Almost 18%

Teva Pharmaceutical Reports Drop in Q3 Profit, Shares Plunge Almost 18%

November 2, 2017

3 Reasons Behind Celgene Corp.’s Abysmal Q3 Earnings Report

3 Reasons Behind Celgene Corp.’s Abysmal Q3 Earnings Report

October 30, 2017

California Judge Throws Out $417M Cancer Verdict Against Johnson & Johnson

California Judge Throws Out $417M Cancer Verdict Against Johnson & Johnson

October 21, 2017

Celgene Abandons Crohn’s Drug, Shares Drop to Four-Month Low

Celgene Abandons Crohn’s Drug, Shares Drop to Four-Month Low

October 20, 2017

A Breakdown of Johnson & Johnson’s Major Sector Revenues Since 2Q17

A Breakdown of Johnson & Johnson’s Major Sector Revenues Since 2Q17

September 27, 2017

Pfizer Files Lawsuit Against Johnson & Johnson

Pfizer Files Lawsuit Against Johnson & Johnson

September 20, 2017

Bayer Funds $100 Million for Agri-Biotech Startup

Bayer Funds $100 Million for Agri-Biotech Startup

September 18, 2017

Teva Pharmaceutical Shares Surged Today, Here’s Why

Teva Pharmaceutical Shares Surged Today, Here’s Why

September 11, 2017

Lung Disease Drug Sends Insmed’s Stock Soaring

Lung Disease Drug Sends Insmed’s Stock Soaring

September 5, 2017

« 1 2 3 4 5 6 … 9 »